Pro-Dex, Inc., together with its subsidiaries, designs, develops, and makes powered surgical instruments for medical device original equipment manufacturers, dental instruments, and rotary air motors worldwide. The company has market cap of $31.18 million. It also makes plastic injection molds for various industries; and machined parts. It has a 5.39 P/E ratio. Further, it provides engineering consulting and placement services, as well as quality and regulatory consulting services.
Today, an insider trading deal was made. William Zollars, the director and an insider of Cigna Corp sold precisely 212 shares of Cigna Corp, worth approximately $43,604 U.S. Dollars, at $205.7 per share at the time of the deal. This deal was reported on January 12, 2018 and is already filed with the Washington-based Security and Exchange Commission. The legal report is on hand for review to the public here. William Zollars owns precisely 0.01% of Cigna Corp’s total market cap or 13,500 shares.
Thompson Davis & Co. Inc. holds 0.05% of its portfolio in Pro-Dex, Inc. for 3,600 shares. First Wilshire Securities Management Inc owns 14,000 shares or 0.03% of their US portfolio. Moreover, Acadian Asset Management Llc has 0% invested in the company for 3,453 shares. The New York-based Blackrock Inc. has invested 0% in the stock. Deutsche Bank Ag, a Germany-based fund reported 30,870 shares.
It closed at $7.15 lastly. It is down 38.82% since January 13, 2017 and is uptrending. It has outperformed by 22.12% the S&P500.
Analysts await Cigna Corporation (NYSE:CI) to report earnings on February, 1. They expect $1.87 earnings per share, 0.00% or $0.00 from last year’s $1.87 per share. CI’s profit will be $461.05M for 28.53 P/E if the $1.87 EPS becomes a reality. After $2.83 actual earnings per share reported by Cigna Corporation for the previous quarter, Wall Street now forecasts -33.92% negative EPS growth.
Cigna Corporation, a health services organization, provides insurance and related services and products in the United States and internationally. The company has market cap of $52.61 billion. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations divisions. It has a 23.37 P/E ratio. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other services and products to insured and self-insured customers.
The stock increased 1.19% or $2.5 during the last trading session, reaching $213.39. About 1.15M shares traded. Cigna Corporation (NYSE:CI) has risen 23.57% since January 13, 2017 and is uptrending. It has outperformed by 6.87% the S&P500.
Among 19 analysts covering CIGNA (NYSE:CI), 15 have Buy rating, 0 Sell and 4 Hold. Therefore 79% are positive. CIGNA has $247.0 highest and $134 lowest target. $199.44’s average target is -6.54% below currents $213.39 stock price. CIGNA had 53 analyst reports since July 27, 2015 according to SRatingsIntel. On Friday, November 3 the stock rating was maintained by Citigroup with “Buy”. Jefferies upgraded Cigna Corporation (NYSE:CI) on Friday, January 8 to “Buy” rating. The stock of Cigna Corporation (NYSE:CI) has “Equal-Weight” rating given on Wednesday, January 6 by Barclays Capital. The rating was maintained by RBC Capital Markets with “Buy” on Monday, September 11. The company was maintained on Monday, May 8 by RBC Capital Markets. The company was maintained on Monday, October 23 by Cowen & Co. The rating was maintained by RBC Capital Markets with “Buy” on Sunday, July 23. The stock of Cigna Corporation (NYSE:CI) has “Buy” rating given on Tuesday, October 10 by Jefferies. The firm has “Buy” rating by RBC Capital Markets given on Monday, August 7. The firm earned “Overweight” rating on Monday, August 7 by Morgan Stanley.
Investors sentiment is 0.96 in Q3 2017. Its the same as in 2017Q2. It is flat, as 47 investors sold Cigna Corporation shares while 249 reduced holdings. only 72 funds opened positions while 212 raised stakes. 206.32 million shares or 5.35% less from 217.98 million shares in 2017Q2 were reported. Pacad Inv has invested 0.25% in Cigna Corporation (NYSE:CI). Dnb Asset Mngmt As holds 102,959 shares. Highland Mgmt Ltd Co invested in 65,373 shares. State Board Of Administration Of Florida Retirement Systems reported 375,214 shares stake. Wafra Inv Advisory Grp Inc Ny holds 78,873 shares or 0.72% of its portfolio. Bell Bank, a North Dakota-based fund reported 1,407 shares. Voya Inv Mgmt has invested 0.04% in Cigna Corporation (NYSE:CI). Deutsche National Bank & Trust Ag invested in 1.19M shares or 0.15% of the stock. Toronto Dominion Fincl Bank has 0.06% invested in Cigna Corporation (NYSE:CI) for 95,683 shares. Lpl Fincl Limited Com invested 0.02% of its portfolio in Cigna Corporation (NYSE:CI). Meyer Handelman holds 0.2% or 23,720 shares in its portfolio. Liberty Mutual Grp Asset Management reported 11,195 shares. Saratoga & Mngmt holds 600 shares or 0.07% of its portfolio. Sumitomo Mitsui Holdings accumulated 738,897 shares. North Carolina-based Boys Arnold And Incorporated has invested 0.05% in Cigna Corporation (NYSE:CI).
Since August 7, 2017, it had 0 buys, and 7 selling transactions for $8.11 million activity. Another trade for 247 shares valued at $45,762 was sold by HARRIS ISAIAH JR. ZOLLARS WILLIAM D also sold $230,662 worth of Cigna Corporation (NYSE:CI) on Wednesday, September 13. $6.65M worth of Cigna Corporation (NYSE:CI) shares were sold by Sadler Jason D. On Wednesday, August 16 Bacus Lisa R sold $402,366 worth of Cigna Corporation (NYSE:CI) or 2,236 shares. $93,232 worth of Cigna Corporation (NYSE:CI) shares were sold by Hoeltzel Mary T. Triplett Michael W had sold 3,700 shares worth $647,360.